About this trial
The study is to evaluate the feasibility of using a non-invasive brain stimulation device in a sample of inpatients with eating disorders (ED). The study will help researchers evaluate whether their device protocol is practical for eating disorder inpatients as a way to manage eating disorder and anxiety symptoms. A secondary aim of the study is to evaluate preliminary effectiveness of the protocol for reducing pre-meal anxiety during the treatment, and explore effects on eating disorder symptoms over the course of the inpatient admission.
Eligibility criteria
Qualifiers
Age 18-30 years old at the time of enrollment
Enrolled in Rogers Behavioral Health Eating Disorder Recovery Program Inpatient Unit at the Oconomowoc, WI clinic location
Have a primary diagnosis of any DSM-5 eating disorder (anorexia nervosa, bulimia nervosa, binge eating disorder, avoidant/restrictive food intake disorder, other specified feeding or eating disorder)
Ability to communicate effectively using written and spoken English
Disqualifiers
Metal in the body of any kind (e.g., braces, pacemakers, metal plates or screws, intracranial electrodes, implanted devices/defibrillators, prostheses)
Currently taking medication that reduces seizure threshold (e.g., clomipramine)
Cranial pathologies (e.g., holes, plates)
History of seizure or black-out concussion
Trial design
Treatments tested in this trial
- Alpha-Stim AID
Treatment groups
Sponsors and collaborators
Rogers Behavioral Health
Lead sponsor
Electromedical Products International, Inc.
Collaborator